sr141716 has been researched along with jwh-133 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chavatte, P; Depreux, P; Farce, A; Goossens, JF; Hénichart, JP; Lambert, DM; Millet, R; Muccioli, GG; Poupaert, JH; Stern, E | 1 |
| Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A | 1 |
| Alauddin, MM; Gelovani, JG; Ivanov, RA; Rabinovich, B; Shavrin, A; Turkman, N; Volgin, A | 1 |
| Borea, PA; Brogi, S; Corelli, F; Di Marzo, V; Falciani, C; Guida, F; Ligresti, A; Luongo, L; Maione, S; Mugnaini, C; Pasquini, S; Pedani, V; Pesco, N; Tafi, A; Varani, K | 1 |
| Carrillo-Salinas, FJ; Fernández-Ruiz, J; Franco, R; Gómez-Cañas, M; Goya, P; Guaza, C; Hurst, DP; Jagerovic, N; Lagartera, L; Morales, P; Navarro, G; Pazos, R; Reggio, PH | 1 |
| Corbacho, C; de Ceballos, ML; Galve-Roperh, I; Gomez del Pulgar, T; Guzmán, M; Huffman, JW; Ramón y Cajal, S; Rueda, D; Sánchez, C; Velasco, G | 1 |
| Barnes, PJ; Belvisi, MG; Birrell, MA; Crispino, N; Hele, DJ; Patel, HJ; Venkatesan, P; Yacoub, MH | 1 |
| Chapman, V; Elmes, SJ; Jhaveri, MD; Kendall, DA; Smart, D | 1 |
| Chapman, V; Kelly, S; Kendall, DA; Millns, PJ; O'Shaughnessey, CT; Sagar, DR | 1 |
| Advenier, C; Chen, HZ; Cui, YY; D'Agostino, B; Finance, O; Marrocco, G; Naline, E; Rinaldi-Carmona, M; Risse, PA; Rossi, F; Zhang, Y | 1 |
| Amato, A; Baldassano, S; Mulè, F; Serio, R | 1 |
| Baker, D; Croxford, JL; Giovannoni, G; Jackson, SJ; Ledent, C; Pertwee, RG; Pryce, G; Yamamura, T | 1 |
| Baldassano, S; Mule', F; Serio, R | 1 |
| Atchison, DK; García, NH; Juncos, LI; Silva, GB | 1 |
| Ding, X; Dong, X; Song, C; Wu, X; Zheng, L | 1 |
| Antoniou, K; Delis, F; Goldberg, SR; Justinova, Z; Nomikos, GG; Polissidis, A; Poulia, N | 1 |
| Beier, JP; Karthaus, N; Kim, BS; Ruhl, T | 1 |
17 other study(ies) available for sr141716 and jwh-133
| Article | Year |
|---|---|
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
Topics: Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2006 |
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism | 2011 |
Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.
Topics: Binding, Competitive; Cell Line, Tumor; Dose-Response Relationship, Drug; Glioma; Humans; Ligands; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship | 2011 |
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists.
Topics: Amides; Animals; CHO Cells; Combinatorial Chemistry Techniques; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Drug Inverse Agonism; HEK293 Cells; Humans; Immunologic Factors; Indoles; Inflammation; Mice; Models, Molecular; Pain; Pain Measurement; Radioligand Assay; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2012 |
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.
Topics: Dose-Response Relationship, Drug; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Multiple Sclerosis; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2016 |
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Benzoxazines; Brain Neoplasms; Camphanes; Cannabinoids; Cell Division; Ceramides; Glioma; Growth Inhibitors; Humans; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.
Topics: Animals; Camphanes; Cannabinoids; Capsaicin; Consciousness; Cough; Cyclohexanols; Dinoprost; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Hypertonic Solutions; In Vitro Techniques; Male; Middle Aged; Neurons, Afferent; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex; Rimonabant; Vagus Nerve | 2003 |
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Topics: Action Potentials; Animals; Camphanes; Cannabinoids; Carrageenan; Disease Models, Animal; Inflammation; Ligation; Male; Neural Inhibition; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Posterior Horn Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sensory Receptor Cells; Spinal Nerves | 2004 |
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Topics: Action Potentials; Animals; Arachidonic Acids; Behavior, Animal; Calcium; Camphanes; Cannabinoids; Capsaicin; Cells, Cultured; Diagnostic Imaging; Dose-Response Relationship, Drug; Drug Interactions; Evoked Potentials; Ganglia, Spinal; Hyperalgesia; Ligation; Male; Neural Inhibition; Neurons; Pain Measurement; Piperidines; Posterior Horn Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord Diseases; Touch | 2005 |
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
Topics: Airway Obstruction; Animals; Benzoxazines; Bronchi; Bronchoconstriction; Camphanes; Cannabinoids; Capillary Permeability; Disease Models, Animal; Dose-Response Relationship, Drug; Esophagus; Extravasation of Diagnostic and Therapeutic Materials; Gastroesophageal Reflux; Guinea Pigs; Hydrochloric Acid; Male; Morpholines; Naphthalenes; Piperidines; Pulmonary Edema; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Respiratory Function Tests; Rimonabant; Trachea | 2007 |
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Cannabinoids; Cholinergic Fibers; Electric Stimulation; Endocannabinoids; Excitatory Postsynaptic Potentials; Gastrointestinal Motility; In Vitro Techniques; Indoles; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Neuromuscular Junction; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Presynaptic; Rimonabant; Stomach; Synaptic Transmission | 2007 |
Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
Topics: Animals; Benzoxazines; Cannabinoids; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Morpholines; Multiple Sclerosis; Naphthalenes; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; T-Lymphocytes | 2008 |
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Topics: Animals; Apamin; Arachidonic Acids; Atropine; Cannabinoid Receptor Modulators; Cannabinoids; Dose-Response Relationship, Drug; Endocannabinoids; Hexamethonium; Ileum; In Vitro Techniques; Indoles; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tetrodotoxin | 2008 |
Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Culture Techniques; Endocannabinoids; Indoles; Ion Transport; Loop of Henle; Male; Morpholines; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen Consumption; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2013 |
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
Topics: Animals; Arachidonic Acids; Cannabinoids; Dose-Response Relationship, Drug; Ethanol; Glutamic Acid; Hippocampus; Indoles; Infarction, Middle Cerebral Artery; Ischemia; Male; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2015 |
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.
Topics: Animals; Cannabinoids; Cocaine; Conditioning, Classical; Indoles; Male; Motor Activity; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2017 |
The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Topics: Adipose Tissue; Benzoxazines; Cannabinoids; Cell Differentiation; Cell Self Renewal; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Mesenchymal Stem Cells; Morpholines; Naphthalenes; Primary Cell Culture; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Regeneration; Rimonabant | 2020 |